Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis
Author:
Affiliation:
1. Department of Dermatology Federation of National Public Service Personnel Mutual Aid Associations Hamanomachi Hospital Fukuoka Japan
2. Department of Dermatology Graduate School of Medical Sciences Kyushu University Fukuoka Japan
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15843
Reference31 articles.
1. Evolving Concepts of Pathogenesis in Atopic Dermatitis and Other Eczemas
2. Pathophysiology of atopic dermatitis: Clinical implications
3. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
4. Pruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey
5. Dupilumab for prurigo nodularis: Case series and review of the literature
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comorbidities of Chronic Prurigo: A Systematic Review and Meta-Analysis;Dermatology;2023-10-26
2. Effectiveness of upadacitinib in Japanese patients with prurigo‐type atopic dermatitis: Four cases report;Journal of Cutaneous Immunology and Allergy;2023-10-09
3. Effectiveness of Dupilumab for Chronic Prurigo in Chinese Patients: A Real-World Case Series Study;Clinical Drug Investigation;2023-09-17
4. Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life;Dermatology;2023-06-27
5. Maintenance of response to dupilumab in prurigo nodularis: A retrospective cohort study;JAAD International;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3